...
机译:ras-活动性肺癌对介质MED23的选择性需求
State Key Laboratory of Cell Biology, Institute of Biochemistry and Cell Biology Chinese Academy of Sciences, Shanghai 200031, China;
State Key Laboratory of Cell Biology, Institute of Biochemistry and Cell Biology Chinese Academy of Sciences, Shanghai 200031, China;
State Key Laboratory of Cell Biology, Institute of Biochemistry and Cell Biology Chinese Academy of Sciences, Shanghai 200031, China;
Key Laboratory of Computational Biology, Chinese Academy of Sciences-Max Planck Institute Partner Institute for Computational Biology, Shanghai Institute for Biological Sciences, Chinese Academy of Sciences, Shanghai 200031, China;
Key Laboratory of Computational Biology, Chinese Academy of Sciences-Max Planck Institute Partner Institute for Computational Biology, Shanghai Institute for Biological Sciences, Chinese Academy of Sciences, Shanghai 200031, China;
State Key Laboratory of Cell Biology, Institute of Biochemistry and Cell Biology Chinese Academy of Sciences, Shanghai 200031, China;
State Key Laboratory of Cell Biology, Institute of Biochemistry and Cell Biology Chinese Academy of Sciences, Shanghai 200031, China;
机译:非小细胞肺癌中介质MED23的上调促进癌细胞的生长,迁移和转移
机译:双TTK / CLK2抑制剂,CC-671,选择性地拮抗ABCG2介导的肺癌细胞的多药耐药性
机译:基于ROS介导的JNK途径激活和NF-Kappa途径抑制的肿瘤选择性MCACs的设计,合成,抗肺癌活性和化学敏感度
机译:核碱基修饰的聚酰胺酰胺介导的miR-23b传递抑制肺癌的增殖和迁移。
机译:阿片类药物需求和癌痛与晚期非小细胞肺癌生存率的关系
机译:PNAS Plus:Ras活性肺癌中介质MED23的选择性要求
机译:双TTK / CLK2抑制剂,CC-671,选择性地拮抗ABCG2介导的肺癌细胞的多药耐药性